RESUMEN
In genome editing with CRISPR-Cas9, transgene integration often remains challenging. Here, we present an approach for increasing the efficiency of transgene integration by homology-dependent repair (HDR). CtIP, a key protein in early steps of homologous recombination, is fused to Cas9 and stimulates transgene integration by HDR at the human AAVS1 safe harbor locus. A minimal N-terminal fragment of CtIP, designated HE for HDR enhancer, is sufficient to stimulate HDR and this depends on CDK phosphorylation sites and the multimerization domain essential for CtIP activity in homologous recombination. HDR stimulation by Cas9-HE, however, depends on the guide RNA used, a limitation that may be overcome by testing multiple guides to the locus of interest. The Cas9-HE fusion is simple to use and allows obtaining twofold or more efficient transgene integration than that with Cas9 in several experimental systems, including human cell lines, iPS cells, and rat zygotes.
Asunto(s)
Proteínas Portadoras/metabolismo , Proteínas Nucleares/metabolismo , Reparación del ADN por Recombinación , Animales , Secuencia de Bases , Sistemas CRISPR-Cas , Proteínas Portadoras/química , Proteínas Portadoras/genética , Línea Celular , Roturas del ADN de Doble Cadena , Endodesoxirribonucleasas , Elementos de Facilitación Genéticos , Femenino , Células HCT116 , Células HEK293 , Recombinación Homóloga , Humanos , Mutación INDEL , Células Madre Pluripotentes Inducidas/metabolismo , Proteínas Nucleares/química , Proteínas Nucleares/genética , Oocitos/metabolismo , Fosforilación , Multimerización de Proteína , ARN Guía de Kinetoplastida/genética , Ratas , Proteínas Recombinantes de Fusión/química , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Transgenes , Integración Viral/genética , Cigoto/metabolismoRESUMEN
Crohn's disease and ulcerative colitis, the two major forms of inflammatory bowel diseases (IBDs), are characterized by high levels of IL-22 production. Rodent studies revealed that this cytokine is protective during colitis but whether this is true in IBDs is unclear. We show here that levels of the soluble inhibitor of IL-22, interleukin 22-binding protein (IL-22BP), are significantly enhanced during IBDs owing to increased numbers of IL-22BP-producing eosinophils, that we unexpectedly identify as the most abundant source of IL-22BP protein in human gut. In addition, using IL-22BP-deficient rats, we confirm that endogenous IL-22BP is effective at blocking protective actions of IL-22 during acute colitis. In conclusion, our study provides new important insights regarding the biology of IL-22 and IL-22BP in the gut and indicates that protective actions of IL-22 are likely to be suboptimal in IBDs thus making IL-22BP a new relevant therapeutic target.
Asunto(s)
Colitis Ulcerosa/inmunología , Enfermedad de Crohn/inmunología , Eosinófilos/inmunología , Interleucinas/inmunología , Receptores de Interleucina/inmunología , Adulto , Animales , Estudios de Casos y Controles , Colitis/inducido químicamente , Colitis/genética , Colitis/inmunología , Colitis/patología , Colitis Ulcerosa/genética , Colitis Ulcerosa/patología , Colon/inmunología , Colon/patología , Enfermedad de Crohn/genética , Enfermedad de Crohn/patología , Sulfato de Dextran , Modelos Animales de Enfermedad , Eosinófilos/metabolismo , Eosinófilos/patología , Femenino , Regulación de la Expresión Génica , Humanos , Interleucinas/genética , Masculino , Persona de Mediana Edad , Ratas , Ratas Sprague-Dawley , Ratas Transgénicas , Receptores de Interleucina/deficiencia , Receptores de Interleucina/genética , Transducción de Señal , Interleucina-22RESUMEN
Xenogenic fetal neuroblasts are considered as a potential source of transplantable cells for the treatment of neurodegenerative diseases, but immunological barriers limit their use in the clinic. While considerable work has been performed to decipher the role of the cellular immune response in the rejection of intracerebral xenotransplants, there is much still to learn about the humoral reaction. To this end, the IgG response to the transplantation of fetal porcine neural cells (PNC) into the rat brain was analyzed. Rat sera did not contain preformed antibodies against PNC, but elicited anti-porcine IgG was clearly detected in the host blood once the graft was rejected. Only the IgG1 and IgG2a subclasses were up-regulated, suggesting a T-helper 2 immune response. The main target of these elicited IgG antibodies was porcine neurons, as determined by double labeling in vitro and in vivo. Complement and anti-porcine IgG were present in the rejecting grafts, suggesting an active role of the host humoral response in graft rejection. This hypothesis was confirmed by the prolonged survival of fetal porcine neurons in the striatum of immunoglobulin-deficient rats. These data suggest that the prolonged survival of intracerebral xenotransplants relies on the control of both cell-mediated and humoral immune responses.
Asunto(s)
Anticuerpos Antiidiotipos/inmunología , Corteza Cerebral/inmunología , Rechazo de Injerto/inmunología , Inmunoglobulina G/inmunología , Neuronas/inmunología , Trasplante Heterólogo , Animales , Anticuerpos Antiidiotipos/farmacología , Células Cultivadas , Corteza Cerebral/citología , Corteza Cerebral/cirugía , Citometría de Flujo , Rechazo de Injerto/metabolismo , Rechazo de Injerto/patología , Supervivencia de Injerto , Técnicas para Inmunoenzimas , Neuronas/citología , Neuronas/trasplante , Ratas , Ratas Endogámicas Lew , PorcinosRESUMEN
Adoptive cell transfer studies in regenerative research and identification of genetically modified cells after gene therapy in vivo require unequivocally identifying and tracking the donor cells in the host tissues, ideally over several days or for up to several months. The use of reporter genes allows identifying the transferred cells but unfortunately most are immunogenic to wild-type hosts and thus trigger rejection in few days. The availability of transgenic animals from the same strain that would express either high levels of the transgene to identify the cells or low levels but that would be tolerant to the transgene would allow performing long-term analysis of labelled cells. Herein, using lentiviral vectors we develop two new lines of GFP-expressing transgenic rats displaying different levels and patterns of GFP-expression. The "high-expresser" line (GFP(high)) displayed high expression in most tissues, including adult neurons and neural precursors, mesenchymal stem cells and in all leukocytes subtypes analysed, including myeloid and plasmacytoid dendritic cells, cells that have not or only poorly characterized in previous GFP-transgenic rats. These GFP(high)-transgenic rats could be useful for transplantation and immunological studies using GFP-positive cells/tissue. The "low-expresser" line expressed very low levels of GFP only in the liver and in less than 5% of lymphoid cells. We demonstrate these animals did not develop detectable humoral and cellular immune responses against both transferred GFP-positive splenocytes and lentivirus-mediated GFP gene transfer. Thus, these GFP-transgenic rats represent useful tools for regenerative medicine and gene therapy.
Asunto(s)
Genes Reporteros , Terapia Genética , Proteínas Fluorescentes Verdes/genética , Ratas Transgénicas/genética , Medicina Regenerativa , Traslado Adoptivo , Animales , Diferenciación Celular , Regulación de la Expresión Génica , Genes Sintéticos , Vectores Genéticos/genética , Proteínas Fluorescentes Verdes/biosíntesis , Lentivirus/genética , Leucocitos/metabolismo , Hígado/metabolismo , Linfocitos/metabolismo , Células Madre Mesenquimatosas/metabolismo , Neuronas/metabolismo , Especificidad de Órganos , Ratas , Ratas Sprague-Dawley , Proteínas Recombinantes de Fusión/análisis , Proteínas Recombinantes de Fusión/biosíntesisRESUMEN
In rat thoracic aorta, the stimulation of endothelial beta3-adrenoceptors (beta-AR) produces a vasorelaxation through activation of a NO synthase pathway and an increase in cGMP levels. In hypertension, a global decrease of the beta-AR response has been described. In spontaneously hypertensive rats (SHR), we have shown that beta3-adrenoceptor-mediated relaxation was not modified in SHR aorta at the age of 12 weeks, in spite of an upregulation of beta3-adrenoceptors. In order to determine the consequences of an over-expression of the beta3-AR, we have developed a transgenic rat over-expressing specifically in endothelial cells the human beta3-AR (Tg beta3). By real-time quantitative PCR, we have determined the expression level of the different beta-AR subtypes. We confirmed an over-expression of the beta3-AR transcripts in Tg beta3 (ratio = 3.39 +/- 0.8; n=3 for Tg beta3 vs wild type [WT] animals). Surprisingly, we observed in Tg beta3 a decrease of beta1-AR transcripts (ratio = 0.76 +/- 0.03; n=3 for Tg beta3 vs WT animals) and no variation for beta2-AR transcripts (ratio = 1.95 +/- 0.60; n=3 for Tg beta3 vs WT animals). In aorta rings from WT and Tg beta3, the isoproterenol-induced relaxation was similar (WT: Emax = 82 +/- 6%, n=6; Tg beta3: Emax = 85 +/- 6, n=6). By contrast, in the presence of 10 microM nadolol, a beta1-, beta2-AR antagonist, the isoproterenol-induced response was significantly increased in Tg beta3 (WT: Emax = 68 +/- 6%, n=6: Tg beta3: Emax = 86 +/- 3; p < 0.01 vs WT). This effect was loss on denuded aortic rings. In conclusion, our study reported similar results to those obtained in hypertension in which a decrease of the beta-AR expression was associated to an elevation of the beta3-AR density. Moreover, this over-expression in our transgenic model is associated to a potential response induced by beta3-AR. Therefore, an activation of beta3-AR could supply the beta1- / beta2-AR decrease. Then, our transgenic model should be used to characterize the physiological consequences of this over-expression as well as to determine the putative involvement of this receptor in the pathogenesis of hypertension.
Asunto(s)
Hipertensión/fisiopatología , Receptores Adrenérgicos beta 3/genética , Receptores Adrenérgicos beta 3/fisiología , Animales , Animales Modificados Genéticamente , Modelos Animales de Enfermedad , Endotelio Vascular/fisiología , Perfilación de la Expresión Génica , Hipertensión/veterinaria , Masculino , Reacción en Cadena de la Polimerasa , Ratas , Ratas Sprague-Dawley , Receptores Adrenérgicos beta 3/biosíntesisRESUMEN
Heme oxygenase-1 (HO-1) expression protects cells from a variety of cellular insults and inhibits inflammation. However, its role in the regulation of immune responses has not yet been clearly established. We generated HO-1 transgenic rats to directly test the impact of HO-1 on the different immune mechanisms. To temporally control the expression of HO-1, we used a one-plasmid tetracycline (tet)-inducible system. This plasmid contains the H-2K(b) promoter, which transcribes the tet transactivator (tTA) and expression of a human HO-1 cDNA is obtained in the absence of tetracycline. The DNA construct was microinjected into one-cell rat embryos and mothers and pups were maintained with tetracycline. Eight transgenic founders were obtained. Analysis of transgene expression in the absence of tet showed that 2 lines (12.4 and 12.6) expressed HO-1 mRNA in several organs (as detected by reverse transcription polymerase chain reaction) and at the protein level only in the thymus. Expression levels of transgene-derived HO-1 increased after withdrawal of tet compared with transgenic rats maintained with tet, as detected by analysis of mRNA levels by quantitative real-time reverse transcription polymerase chain reaction. Gross examination and histopathological analysis of several organs in both lines showed no anomalies. Thymocytes and splenocytes of both lines showed normal cell subpopulations and allogeneic proliferation compared with controls. Systemic immune responses against cognate antigens were normal in both lines, as evaluated by the proliferation of lymph node cells and the production of antibodies against keyhole limpet hemocyanin after immunization. Animals from line 12.6 rejected transplanted allogeneic hearts with the same kinetics as controls. In conclusion, short-term induction of HO-1 overexpression did not modify immune responses compared to those of control non-transgenic animals.
Asunto(s)
Animales Modificados Genéticamente , Regulación Enzimológica de la Expresión Génica , Hemo Oxigenasa (Desciclizante)/genética , Hemo Oxigenasa (Desciclizante)/metabolismo , Animales , Células Cultivadas , Supervivencia de Injerto , Hemo-Oxigenasa 1 , Humanos , Leucocitos/metabolismo , Proteínas de la Membrana , Regiones Promotoras Genéticas , Ratas , Ratas Sprague-Dawley , Timo/citología , Timo/enzimología , Transgenes , Trasplante HomólogoAsunto(s)
Antígenos CD55/inmunología , Circulación Coronaria , Endotelio Vascular/inmunología , Rechazo de Injerto/inmunología , Trasplante de Corazón/inmunología , Leucocitos/inmunología , Animales , Animales Modificados Genéticamente , Antígenos CD55/genética , Adhesión Celular , Moléculas de Adhesión Celular/metabolismo , Supervivencia de Injerto/inmunología , Humanos , Inmunidad Celular , Selectina-P/metabolismo , RatasRESUMEN
BACKGROUND: In the hamster-to-rat heart xenotransplantation model, the serum response of the host contributes to determine whether the xenograft is accommodated or rejected. METHODS: To further characterize the serum response in this model, we compared anti-hamster antibodies found in naive LEW-1A rats, or in LEW-1A rats rejecting or accommodating a hamster heart, using a combination of cobra venom factor (CVF) and cyclosporin A (CsA) given for 10 days, and then CsA alone. RESULTS: Hamster hearts grafted into rat recipients contained IgG and IgA deposits to the same extent whether the xenograft was rejected or accommodated. Only immunoglobulins of the IgM isotype were found to be more abundant in recipients rejecting their graft. A significant part of this IgM response was directed toward the Forssman antigen, a sphingolipid present in the hamster but not in the rat. However, although anti-Forssman antibodies bind in situ to hamster tissues, this binding was not able to induce hyperacute rejection after antibody transfer. Furthermore, depletion of anti-Forssman antibodies from a rejecting serum did not modify its rejection properties. CONCLUSION: Unlike the pig-to-primate discordant xenotransplantation model, in which preexisting anti-carbohydrate antibodies are directly responsible for hyperacute rejection, in the concordant hamster-to-rat situation, the evoked IgM anti-Forssman carbohydrate antibodies do not appear to be the main cause of the vascular rejection.
Asunto(s)
Anticuerpos Heterófilos/inmunología , Trasplante de Corazón , Trasplante Heterólogo , Animales , Formación de Anticuerpos , Cricetinae , Células Epiteliales/inmunología , Antígeno de Forssman/inmunología , Rechazo de Injerto/inmunología , Trasplante de Corazón/inmunología , Inmunoglobulina M/análisis , Linfocitos/inmunología , Miocardio/inmunología , RatasRESUMEN
BACKGROUND: Many patients with renal failure are condemned to long-term dialysis with little prospect of transplantation because they are highly sensitized with immunoglobulin G (IgG) directed against class I human leukocyte antigens (HLA) of virtually all donors. Xenotransplantation could represent an attractive solution providing their alloantibodies (alloAb) do not recognize porcine motifs. Hitherto there has been no in vivo demonstration of any cross-reactivity and the objective of this work was to investigate this problem using a technique of extracorporeal pig kidney perfusion as a model of clinical xenografting. METHODS: Pig kidneys were perfused ex vivo with plasma from both a group of highly sensitized patients and healthy individuals. Sequential plasma samples were analyzed for the titer of anti-Galalpha1-3Gal antibody (Ab) (major natural xenoreactive Ab) by enzyme-linked immunosorbent assay and anti-HLA class I Ab against a cell panel. At the end of perfusion, kidneys were perfused with a citric acid buffer to elute bound Ab. RESULTS: Galalpha1-3Gal Ab were shown to decrease rapidly in the plasma (in less than 10 min) and then reached a plateau. A fractional decrease in anti-HLA Ab was also found in some of the perfused plasma samples. Anti-Gal Ab were readily detected in all citric acid perfusates and anti-HLA Ab in 8 of 10. The HLA specificities of eluted Ab were mainly concordant with the originally designated specificities for each patient. CONCLUSION: Anti-HLA class I Ab presumably cross-react with pig class I homologues. However, some plasma samples did not cross-react, suggesting that negatively cross-matched pig kidneys could be identified in the pig population for xenotransplantation in these patients. Further studies are required to precisely describe these cross-reactivities and to understand their functional significance in xenotransplantation.
Asunto(s)
Anticuerpos/inmunología , Antígenos Heterófilos/inmunología , Reacciones Cruzadas , Antígenos HLA/inmunología , Porcinos/inmunología , Animales , Sangre/inmunología , Disacáridos/inmunología , Herpesvirus Humano 4/inmunología , Humanos , Inmunización , Inmunoglobulina G/análisis , Inmunoglobulina G/inmunología , Técnicas Inmunológicas , Técnicas In Vitro , Riñón/inmunología , Riñón/patología , Cinética , Perfusión , Coloración y EtiquetadoRESUMEN
BACKGROUND: Production of transgenic pigs for multiple transgenes is part of a potential strategy to prevent immunological events involved in xenograft rejection. Use of a genetically engineerable rodent as a donor in primates could allow testing in vivo of the effects of different transgenes on controlling xenograft rejection. As a first step in the development of a donor containing multiple transgenes, transgenic rats for human decay-accelerating factor (DAF) were used as heart donors to test their resistance against complement (C)-mediated rejection by non-human primates. MATERIALS AND METHODS: Transgenic rats were generated by using a construct containing the human DAF cDNA under the transcriptional control of the endothelial cell (EC)-specific human ICAM-2 promoter. DAF expression was evaluated by immunohistology and by FACS analysis of purified ECs. Resistance of transgenic hearts against C-mediated damage was evaluated by ex vivo perfusion with human serum and by transplantation into cynomolgus monkeys. RESULTS: Immunohistological analysis of DAF expression in several organs from two transgenic lines showed uniform expression on the endothelium of all blood vessels. ECs purified from transgenic hearts showed 50% DAF expression compared to human ECs and >70% reduction of C-dependent cell lysis compared to control rat ECs. Hemizygous transgenic hearts perfused with human serum showed normal function for >60 min vs. 11. 2 +/- 1.7 min in controls. Hemi- or homozygous transgenic hearts transplanted into cynomolgus monkeys showed longer survival (15.2 +/- 7 min and >4.5 hr, respectively) than controls (5.5 +/- 1.4 min). In contrast to hyperacutely rejected control hearts, rejected homozygous DAF hearts showed signs of acute vascular rejection (AVR) characterized by edema, hemorrhage, and an intense PMN infiltration. CONCLUSIONS: We demonstrate that endothelial-specific DAF expression increased heart transplant survival in a rat-to-primate model of xenotransplantation. This will aid in the analysis of AVR and of new genes that may inhibit this form of rejection, thus helping to define strategies for the production of transgenic pigs.
Asunto(s)
Antígenos CD55/genética , Rechazo de Injerto/prevención & control , Trasplante de Corazón , Trasplante Heterólogo , Animales , Animales Modificados Genéticamente , Anticuerpos/metabolismo , Endotelio/metabolismo , Femenino , Rechazo de Injerto/patología , Humanos , Inmunohistoquímica , Técnicas In Vitro , Macaca fascicularis , Masculino , Miocardio/patología , Necrosis , Neutrófilos/patología , Perfusión , Ratas , Ratas Endogámicas , Ratas Sprague-Dawley , TransgenesAsunto(s)
Criopreservación/métodos , Embrión de Mamíferos , Animales , Fase de Segmentación del Huevo , Crioprotectores , Medios de Cultivo , Dimetilsulfóxido , Transferencia de Embrión , Estudios de Evaluación como Asunto , Femenino , Embarazo , Propilenglicol , Ratas , Ratas Sprague-Dawley , SacarosaAsunto(s)
Endotelio Vascular/metabolismo , Regulación de la Expresión Génica/efectos de los fármacos , Glicoproteínas de Membrana/genética , Resistencia a la Tetraciclina/genética , Tetraciclina/farmacología , Animales , Animales Modificados Genéticamente , Apoptosis , ADN/genética , ADN/metabolismo , Endotelio Vascular/citología , Endotelio Vascular/efectos de los fármacos , Proteína Ligando Fas , ARN Mensajero/genética , ARN Mensajero/metabolismo , RatasRESUMEN
Donor-specific (DST) or nonspecific blood transfusions administered before transplantation can enhance survival of vascularized allografts both in humans and animals but the immunological mechanisms of this effect remain unclear. We have analyzed the expression and the role of endogenous TGF-beta1 in a model of heart allograft tolerance, induced by pregraft DST in adult rats. We reported previously that this tolerance occurs despite a strong infiltration of leukocytes into the graft that are unable to produce both Th1- and Th2-related cytokines in vivo. Allografts from DST-treated rats express high levels of TGF-beta1 mRNA and active protein. This phenomenon is correlated with the rapid infiltration of leukocytes producing high amounts of TGF-beta1. TGF-beta1-producing cells are virtually absent among early infiltrating cells in rejected grafts but are found at a later time point. The induction of allograft tolerance in vivo is abrogated by administration of neutralizing anti-TGF-beta mAb. Moreover, overexpression of active TGF- beta1 in heart allografts using a recombinant adenovirus leads to prolonged graft survival in unmodified recipients. Taken together, our results identify TGF-beta as a critical cytokine involved in the suppression of allograft rejection induced by DST and suggest that TGF-beta-producing regulatory cells are also involved in allograft tolerance.
Asunto(s)
Transfusión Sanguínea , Refuerzo Inmunológico de Injertos , Supervivencia de Injerto/fisiología , Trasplante de Corazón , Factor de Crecimiento Transformador beta/fisiología , Animales , Anticuerpos Monoclonales/farmacología , Rechazo de Injerto/inmunología , Leucocitos/metabolismo , Prueba de Cultivo Mixto de Linfocitos , Masculino , ARN Mensajero/biosíntesis , Ratas , Ratas Endogámicas BUF , Ratas Endogámicas Lew , Bazo/inmunología , Donantes de Tejidos , Factor de Crecimiento Transformador beta/antagonistas & inhibidores , Factor de Crecimiento Transformador beta/biosíntesis , Factor de Crecimiento Transformador beta/inmunología , Trasplante HomólogoAsunto(s)
Antígenos CD/biosíntesis , Antígenos CD55/biosíntesis , Antígenos CD59/biosíntesis , Activación de Complemento , Trasplante Heterólogo/inmunología , Animales , Animales Modificados Genéticamente , Linfocitos B/inmunología , Transferencia de Embrión , Femenino , Humanos , Embarazo , Ratas , Ratas Sprague-Dawley , Bazo/inmunología , Superovulación , Linfocitos T/inmunología , Timo/inmunologíaAsunto(s)
Rechazo de Injerto/inmunología , Receptores de Antígenos de Linfocitos T alfa-beta/biosíntesis , Animales , Cartilla de ADN , Prueba de Histocompatibilidad , Complejo Mayor de Histocompatibilidad , Reacción en Cadena de la Polimerasa , Ratas , Ratas Endogámicas Lew , Receptores de Antígenos de Linfocitos T alfa-beta/análisis , Trasplante HomólogoRESUMEN
Following allotransplantation, determinants encoded within the donor MHC are recognized by recipient T lymphocytes through their Ag receptor. In this study, we investigated the TCR Vbeta chain diversity of T cells infiltrating rejected and tolerated heart allografts in a model of donor-specific blood transfusion-induced tolerance in MHC-mismatched congeneic rats. The PCR-based method that we used allows the diversity of Vbeta chains at the complementarity-determining region 3 level to be analyzed quantitatively. Our results show that the Vbeta repertoire usage in graft-infiltrating T cells was characteristic and different in tolerated compared with rejected grafts, and differed in both cases from the normal distribution of the Vbeta repertoire. An expansion of lymphocytes showing a conserved Vbeta18-Dbetal-Jbeta2.7 gene rearrangement was found, from the first day after grafting onward, in graft-infiltrating cells from all tolerant animals. This clone accounted for as much as 5% of the whole Vbeta repertoire in tolerated hearts, as evidenced by RNase protection assay. In contrast, we demonstrated that, of lymphocytes infiltrating rejected grafts, those with a Vbeta18 chain were diverse, and that even though by day 5 the conserved Vbeta18-Dbeta1-Jbeta2.7 rearrangement was detectable, lymphocytes harboring this rearrangement represented less than 0.6% of the whole TCR-alphabeta+ T cell repertoire. Kinetics analysis revealed that the expansion of lymphocytes bearing this conserved rearrangement was elicited specifically by donor blood transfusion. Indeed, Vbeta18-Dbeta1-Jbeta2.7 transcripts were detected in PBL from transfused animals as early as 7 days after donor-specific blood transfusion. Finally, we provided evidence that this T cell clone belongs to the CD8+ subset. The putative role in inducing and maintaining the allograft tolerance of the CD8+ T cell clone harboring this public Vbeta18-Dbeta1-Jbeta2.7 rearrangement is discussed.
Asunto(s)
Transfusión Sanguínea , Trasplante de Corazón/inmunología , Tolerancia Inmunológica , Receptores de Antígenos de Linfocitos T alfa-beta/inmunología , Animales , Secuencia de Bases , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/inmunología , Reordenamiento Génico de la Cadena beta de los Receptores de Antígenos de los Linfocitos T , Genes Dominantes , Histocompatibilidad , Masculino , Ratones , Datos de Secuencia Molecular , Ratas , Ratas Endogámicas Lew , Trasplante HomólogoRESUMEN
Specific tolerance to LEW.1W (RT1u) heart allografts can be induced in adult LEW.1A (RT1a) rats by donor-specific blood transfusion (DST). We have previously shown that both rejected and tolerated grafts are heavily infiltrated by T lymphocytes, and that in both cases these T cells are capable of developing similar cytotoxic responses against donor cells in vitro; tolerance is therefore not due to the deletion of alloreactive T cells. At the same time, we found that the accumulation of IL-2 and IFN-gamma mRNA was decreased in tolerated grafts compared with rejected grafts. These results suggested that the induction of allograft tolerance in DST-treated animals could be mediated by anergy or suppression of graft-infiltrating Th1 cells. Although Th1 and Th2 clones have not yet been characterized in the rat, peripheral CD4+ rat T cells can be divided into two populations, based on their expression of the isoform RC of the CD45 molecule. Upon activation, CD45RChigh CD4+ T cells produce IL-2 and IFN-gamma and responsible for the induction of the graft-versus-host reaction, whereas CD45RClow CD4+ T cells produce IL-4 in vitro and provide B cell help. In the present study, we show that heart allografts from both DST-treated and untreated rats were infiltrated by equivalent numbers of leukocytes, of which CD4+ T cells also made up similar percentages. Among these CD4+ T cells, we observed that in allografts from DST-treated recipients the CD45RChigh population on day 5 was very significantly smaller (P = 0.004) than in the untreated group, while CD45RClow populations remained comparable. Moreover, using a new quantitative RT-PCR method, we found a dramatic reduction in the accumulation of IL-2, IFN-gamma, IL-10, IL-4, and IL-13 mRNA in hearts from DST-treated recipients compared with those of untreated recipients during the week following transplantation. These results show that in heart allografts from DST-treated recipients, despite phenotypic changes suggesting Th1 inhibition by Th2 imbalance, T helper function was inhibited as a whole, and that in vivo the phenotype CD4+ CD45RClow does not always correlate with Th2-related cytokine-producing cells.
Asunto(s)
Transfusión Sanguínea , Citocinas/genética , Trasplante de Corazón/inmunología , Tolerancia Inmunológica , Antígenos Comunes de Leucocito/análisis , Linfocitos T Colaboradores-Inductores/inmunología , Animales , Secuencia de Bases , Masculino , Datos de Secuencia Molecular , ARN Mensajero/análisis , Ratas , Ratas Endogámicas Lew , Trasplante HomólogoRESUMEN
Allospecific T lymphocytes mediate graft rejection through specific, direct or indirect, recognition of processed determinants of foreign MHC class I molecules. Small synthetic peptides derived from highly conserved sequences of the alpha 1 helix of the first domain of certain MHC class I molecules have been shown to inhibit CTL responses in vitro and to prolong graft survival in rats when combined with subtherapeutic doses of cyclosporine. Here, we report that the survival of LEW.1W heart allografts was significantly prolonged when transplanted into congenic LEW.1A recipients treated only with a peptide corresponding to residues 75-84 of the human HLA-B7-01 molecule (B7.75-84) before transplantation. The experimental value for mean survival time (+/- SD) in untreated recipients was 13 +/- 6 days and in peptide-treated recipients was 42 +/- 27 days (P < 0.002). A total of 64% of treated recipients had a functioning graft at 30 days, while grafts were rejected in all rats belonging to the control group within this time. Within graft-infiltrating leukocytes (GIL) in B7.75-84-treated animals, the proportion of T cells was significantly lower and that of CD5-/TCR alpha beta-/CD16-/CD8+ and MHC class II+ cells concomitantly increased, as compared with nontreated animals. GIL from B7.75-84-treated animals also exhibited a dramatic decrease (approximately 70%) of allospecific and spontaneous (NK) cytotoxic activity, whereas their proliferation and IL-2 production were similar in both experimental groups. The IFN-gamma, IL-2, and IL-10 mRNA levels from GIL from peptide-treated recipients were similar to levels of controls, reflecting a state of activation of GIL. Perforin and granzyme A mRNA, the level of which may be modulated parallel to impaired cytotoxic functions, were at similar levels in both experimental groups. These data demonstrate that B7.75-84 significantly prolongs graft survival in LEW.1A rats when given as a single agent and suggests that a specifically decreased cytotoxic response (allospecific and spontaneous) plays a major role.
Asunto(s)
Antígeno HLA-B7/química , Trasplante de Corazón/inmunología , Fragmentos de Péptidos/farmacología , Abdomen , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Northern Blotting , Citocinas/genética , Supervivencia de Injerto/efectos de los fármacos , Granzimas , Interferón gamma/genética , Interleucina-10/genética , Interleucina-2/genética , Activación de Linfocitos , Masculino , Glicoproteínas de Membrana/genética , Datos de Secuencia Molecular , Perforina , Fenotipo , Reacción en Cadena de la Polimerasa , Proteínas Citotóxicas Formadoras de Poros , Estructura Secundaria de Proteína , ARN Mensajero/análisis , Ratas , Ratas Endogámicas Lew , Serina Endopeptidasas/genética , Linfocitos T Citotóxicos/inmunología , Transcripción Genética , Trasplante HeterotópicoAsunto(s)
Citotoxicidad Inmunológica , Supervivencia de Injerto/inmunología , Antígeno HLA-B7/uso terapéutico , Trasplante de Corazón/inmunología , Fragmentos de Péptidos/uso terapéutico , Linfocitos T/inmunología , Animales , Expresión Génica/inmunología , Supervivencia de Injerto/efectos de los fármacos , Antígeno HLA-B7/química , Trasplante de Corazón/patología , Humanos , Interferón gamma/biosíntesis , Interleucina-10/biosíntesis , Interleucina-2/biosíntesis , Activación de Linfocitos , Masculino , Fragmentos de Péptidos/química , Reacción en Cadena de la Polimerasa , Estructura Secundaria de Proteína , ARN Mensajero/análisis , ARN Mensajero/biosíntesis , Ratas , Ratas Endogámicas Lew , Bazo/inmunología , Trasplante HomólogoRESUMEN
Permanent tolerance to allografts can be induced in adult rats by donor-specific transfusions (DST) prior to transplantation. We have previously reported, in a model of heart allograft, the presence of a heavy leukocyte infiltrate, in the allograft which displayed a strong allospecific cytotoxicity when tested in vitro against donor cells, and a strong accumulation of mRNA for granzyme A and perforin in vivo. In contrast, there was a major decrease in the accumulation of mRNA for interleukin-2 and interferon-gamma. These results suggested that the DST-induced tolerance was associated with a decrease in type-1 T helper (Th1) cell function. The major role of preformed antibodies in xeno and allorejection is clearly established. Nevertheless, the consequences of alloantibody production in acute rejection and tolerance induction remains to be elucidated. We here analyze the alloantibody response in rejecting and DST-treated recipients. We show that, after transplantation, tolerant recipients, in contrast to rejecting ones, mount a low IgM alloresponse that switches to low IgG production. Detailed analysis of IgG alloantibodies in DST-treated recipients revealed that their production decrease was not equally distributed. Whereas rejecting animals mounted a strong anti-class I and II IgG alloantibody response, DST-treated recipients produced anti-class II and low titers of anti-class I IgG alloantibodies. Furthermore, among IgG subclasses, tolerant recipients predominantly produced IgG2a, a profile which, in the rat, is compatible with a Th2-controlled response. Finally, the passive transfer of immune serum from rejecting animals to DST-treated recipients could abrogate the tolerance. We suggest that the absence of anti-class I alloantibodies combined with preserved and/or increased anti-class II production plays a major role in graft tolerance in this model. These results reinforced the role of alloantibodies in rejection and in induction of tolerance.